You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermittent Androgen Suppression

Showing 1 - 25 of 4,735
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial (iMAB, cMAB)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jul 26, 2023

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Castration Sensitive Prostate Cancer Trial in Little Rock (Metformin, Turmeric)

Not yet recruiting
  • Castration Sensitive Prostate Cancer
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 12, 2023

Metastatic Castrate-sensitive Prostate Cancer Trial in Germany, United States (Apalutamide, Androgen-deprivation Therapy (ADT))

Not yet recruiting
  • Metastatic Castrate-sensitive Prostate Cancer
  • Lakewood, Colorado
  • +5 more
May 23, 2023

Prostate Cancer Trial in United States (Radiation, Androgen Suppression Therapy)

Recruiting
  • Prostate Cancer
  • Radiation
  • Androgen Suppression Therapy
  • Scottsdale, Arizona
  • +3 more
Oct 24, 2021

Prostate Cancer Trial in United States (Niraparib, Leuprolide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Oct 18, 2022

Prostate Cancer Trial in Baltimore (Flutamide, Placebo)

Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    SKCCC at Johns Hopkins
Sep 2, 2021

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Prostate Cancer Trial in London (Radiation, Androgen Suppression)

Completed
  • Prostate Cancer
  • Radiation
  • Androgen Suppression
  • London, Ontario, Canada
    London Regional Cancer Program of the Lawson Health Research Ins
Jun 1, 2021

Prostate Cancer Trial in Canada (bicalutamide, buserelin, cyproterone acetate)

Completed
  • Prostate Cancer
  • Calgary, Alberta, Canada
  • +28 more
Jun 21, 2021

Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)

Recruiting
  • Hyperandrogenism
  • +2 more
  • Micronized progesterone
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Clinical Research Unit
May 16, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Cancer of the Prostate Trial in United States (BHR-200 (0.36% transdermal 17ß-estradiol gel), Placebo)

Terminated
Has Results
  • Cancer of the Prostate
  • BHR-200 (0.36% transdermal 17β-estradiol gel)
  • Placebo
  • Tucson, Arizona
  • +11 more
Mar 8, 2022

Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Stage III Prostate Cancer
  • stereotactic body radiation therapy
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Apr 28, 2022

Prostate Cancer, Oligometastasis Trial in France (IADT, IADT + radiotherapy)

Recruiting
  • Prostate Cancer
  • Oligometastasis
  • IADT
  • IADT + radiotherapy
  • Avignon, France
  • +15 more
Dec 28, 2021

Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)

Recruiting
  • Prostatic Neoplasms
  • Cheongju, Korea, Republic of
  • +9 more
Jul 28, 2021

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • ipilimumab
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
  • +1 more
Sep 23, 2020

Prostate Cancer Trial in Toronto (SBRT, Hormone therapy)

Recruiting
  • Prostate Cancer
  • SBRT
  • Hormone therapy
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Dec 1, 2020

Prostate Cancer Trial in Surrey, Victoria (stereotactic ablative radiotherapy, external beam radiation therapy, Zoladex ®)

Active, not recruiting
  • Prostate Cancer
  • stereotactic ablative radiotherapy
  • +2 more
  • Surrey, British Columbia, Canada
  • +1 more
Oct 26, 2020

Stroke, Hemiplegia Trial in Hong Kong (Intermittent theta burst stimulation, Mirror Therapy, Sham intermittent theta burst

Recruiting
  • Stroke
  • Hemiplegia
  • Intermittent theta burst stimulation
  • +3 more
  • Hong Kong, Hong Kong
    Kenneth FONG
Dec 7, 2020

Prostate Cancer Trial in Seattle (Exisulind, luteinizing hormone-releasing hormone (LHRH) agonist, Antiandrogen)

Completed
Has Results
  • Prostate Cancer
  • Seattle, Washington
    Seattle Cancer Care Alliance
Aug 3, 2018

Metastatic Castration-Resistant Prostate Cancer Trial in Baltimore, Detroit, Madison (PCUR - 101)

Terminated
  • Metastatic Castration-Resistant Prostate Cancer
  • PCUR - 101
  • Baltimore, Maryland
  • +2 more
Mar 5, 2020

Prostate Cancer Trial in Canada (drug, procedure, radiation)

Terminated
  • Prostate Cancer
  • Calgary, Canada
  • +12 more
Mar 31, 2020